>
Procedures
>
Therapeutic or Preventive Procedure
>
Hemodialysis
Hemodialysis
Hemodialysis is a process of purifying the blood of a patient with kidney failure.
It involves removing waste, excess water, and other impurities from the blood using a dialysis machine.
This procedure is typically performed three times per week and can help manage symptoms associated with end-stage renal disease.
Hemodialysis plays a vital role in the treatment and management of chronic kidney disease, allowing patients to maintain their health and quality of life.
Understanding the latest advancements in hemodialysis research is crucial for optimizing patient outcomes and enhancing reproducibility in related studies.
It involves removing waste, excess water, and other impurities from the blood using a dialysis machine.
This procedure is typically performed three times per week and can help manage symptoms associated with end-stage renal disease.
Hemodialysis plays a vital role in the treatment and management of chronic kidney disease, allowing patients to maintain their health and quality of life.
Understanding the latest advancements in hemodialysis research is crucial for optimizing patient outcomes and enhancing reproducibility in related studies.
Most cited protocols related to «Hemodialysis»
This study aimed at assessing measurement properties for 3L and 5L in eight broad patient groups. A student cohort was added in order to investigate how both instruments perform in a healthy population sample. Respondents completed both the 3L and 5L in six countries: Denmark, England, Italy, the Netherlands, Poland, and Scotland. Data collection in Denmark was conducted through the endocrinology, rheumatology, and orthopedic departments of a regional university hospital. Data collection in England was organized through a specialist patient recruitment agency and aimed at patients with prespecified conditions. In Italy the cohort of liver disease patients completed the questionnaires locally at two hospitals (Bergamo and Naples). Data collection in the Netherlands was conducted at a specialist center for personality disorders and at a local hospital for the kidney dialysis patients. In Poland, the student cohort was recruited at the Medical University of Warsaw in Poland, and the stroke cohort was recruited through the Neurological Clinic in Warsaw. Data collection in Scotland took place through a specialist patient recruitment agency, with patients completing the questionnaires at primary care centers. Paper and pencil versions of the questionnaires were used in all countries except in England where data collection took place online. Data collection took place between August 2009 and September 2010. The 5L was administered first, followed by the EQ-5D visual analogue scale (EQ-VAS) and a number of demographic questions, then the 3L, and finally a set of five dimension-specific rating scales. All respondents scored 5L first, as a previous study showed a tendency to avoid the in-between levels 2 and 4 of 5L when responding to the 3L first [20 (link)]. Data collection was undertaken with informed consent and according to the ethical guidelines for health research in each country.
Full text: Click here
Cerebrovascular Accident
Hemodialysis
Liver Diseases
Patients
Personality Disorders
Population Health
Primary Health Care
Student
System, Endocrine
Visual Analog Pain Scale
Acute Coronary Syndrome
Adult
Chronic Kidney Diseases
Congestive Heart Failure
Diabetes Mellitus
Diabetes Mellitus, Non-Insulin-Dependent
Dialysis
Ethics Committees, Research
Health Literacy
Hemodialysis
High Blood Pressures
Inpatient
Kidney Diseases
Outpatients
Patients
Pharmaceutical Preparations
Primary Health Care
Arteriovenous Anastomosis
Cannulation
Dialysis
Eligibility Determination
Fistula
Hemodialysis
Operative Surgical Procedures
austin
Biopsy
Bronchoscopy
Catheterizations, Cardiac
Colonoscopy
Endoscopy
Hemodialysis
Hospitalists
Hospitalization
Hypersensitivity
Inpatient
Kidney
Liver
Outpatients
Patients
Peritoneal Dialysis
Physicians
The primary outcome was all-cause mortality within 28 days after randomization; further analyses were specified at 6 months. Secondary outcomes were the time until discharge from the hospital and, among patients not receiving invasive mechanical ventilation at the time of randomization, subsequent receipt of invasive mechanical ventilation (including extracorporeal membrane oxygenation) or death. Other prespecified clinical outcomes included cause-specific mortality, receipt of renal hemodialysis or hemofiltration, major cardiac arrhythmia (recorded in a subgroup), and receipt and duration of ventilation.
Cardiac Conduction System Disease
Extracorporeal Membrane Oxygenation
Hemodialysis
Hemofiltration
Kidney
Mechanical Ventilation
Patient Discharge
Patients
Most recents protocols related to «Hemodialysis»
We identified candidate predictors from the literature and input from clinicians with expertise in kidney failure and perioperative medicine. The final list of variables included demographics of age and sex. Surgeries were categorized into 11 surgery types based on CCI codes, including categories that are specific to people with kidney failure (kidney transplant, peritoneal dialysis catheter insertion, and AV fistula creation). Surgery setting was classified using the administrative data as ambulatory elective, inpatient elective, or inpatient urgent/emergent. We considered comorbidities of previous AMI, cancer, chronic pulmonary disease, dementia, diabetes, heart failure, hypertension, liver disease, obesity, peripheral vascular disease, and stroke. These were defined using validated algorithms of International Statistical Classification of Diseases and Related Health Problems Ninth and Tenth Revision (ICD-9-CM and ICD-10-CA) codes [17 (link)] with an unrestricted lookback period for permanent conditions and 3 years for temporary conditions (Supplementary Tables 3 and 4 ). Kidney failure treatment modality was categorized as non-dialysis, hemodialysis, or peritoneal dialysis. Preoperative outpatient serum albumin (in g/L) and serum hemoglobin (in g/L) within the year before surgery were included as candidates. There were no missing values for variables except for albumin (15%) and hemoglobin (0.2%), which were imputed using multivariable normal regression with an iterative Markov chain Monte Carlo method.
Full text: Click here
Albumins
Catheterization
Cerebrovascular Accident
Congestive Heart Failure
Dementia
Diabetes Mellitus
Disease, Chronic
Fistula, Arteriovenous
Hemodialysis
Hemoglobin
High Blood Pressures
Inpatient
Kidney
Kidney Failure
Kidney Transplantation
Liver Diseases
Lung
Lung Diseases
Malignant Neoplasms
Menstruation Disturbances
Obesity
Operative Surgical Procedures
Outpatients
Peripheral Vascular Diseases
Peritoneal Dialysis
Serum
Serum Albumin
We included all adults (≥ 18 years) with an inpatient or ambulatory surgery performed between April 1 2005 and February 28 2019 in Alberta, Canada. Surgeries were identified using the Canadian Classification of Health Interventions (CCI) coding [14 ], which is a standardized coding system for procedures. Radiologic or non-surgical procedures were excluded (e.g., endoscopy, hemodialysis catheter insertion, arteriovenous [AV] fistulogram, etc.). Further, we included only those with preoperative kidney failure, defined as an eGFR < 15 mL/min/1.73m2 or receiving hemodialysis or peritoneal dialysis for at least 90 days as an outpatient before the index surgical procedure. For non-dialysis participants, at least two outpatient measures of serum creatinine between 7–365 days were necessary prior to surgery to avoid misclassification of people with preoperative acute kidney injury, per a validated algorithm [15 (link)]. We estimated eGFR using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation without including the Black race coefficient [16 (link)]. We excluded people that left Alberta within 30 days of their surgery, and those without available demographic data.
Full text: Click here
Adult
Ambulatory Surgical Procedures
Catheterization
Creatinine
Dialysis
EGFR protein, human
Endoscopy
Hemodialysis
Inpatient
Kidney Failure
Kidney Injury, Acute
Negroes
Operative Surgical Procedures
Outpatients
Peritoneal Dialysis
Serum
All hemodialysis patients aged>18 years of the two dialysis units who had
been treated with chronic outpatient intermittent hemodialysis for at least
three months were asked to participate in the study. Patients with impaired
vision that might interfere with SMBG, reading FGM values, and completing a
study diary were excluded. Further exclusion criteria were a history of allergic
reaction to the material of FreeStyle Libre and regular intake of paracetamol as
it potentially interferes with the measurement method
8 (link)
9 (link)
21 (link)
. The patient
screening was based on patient history in the electronic health records.
Acetaminophen
Dialysis
Hemodialysis
Outpatients
Patients
The primary outcome is to assess the QoL in CKD patients undergoing hemodialysis and its associated factors. The secondary outcome is to measure the internal consistency of the subscales.
Hemodialysis
Patients
Adult patients (aged ≥18 years) with ESKD who underwent hemodialysis at King Salman Center for Kidney Disease (KSCKD) and King Fahad Medical City (KFMC), Riyadh, Saudi Arabia, between June and July 2021, and had been on dialysis for ≥1 year were included in this cross-sectional study if they consented to participate. Patients who had cognitive impairment and/or debilitating diseases (except hypertension, diabetes, and cardiovascular diseases) were excluded from the study to avoid confounding effects. This study used convenience sampling.
KSCKD is the main outpatient dialysis unit in Riyadh Second Health Cluster, and the largest dialysis center in Riyadh with a total capacity of 600 patients, and with >52,000 hemodialysis sessions per year.[12 ] The dialysis unit at KFMC, a tertiary hospital at Riyadh Second Health Cluster, has a total capacity of up to 100 patients. KSCKD and KFMC are two of the largest centers for both hemodialysis and peritoneal dialysis not only in Saudi Arabia but also in the Middle East. Therefore, the patient population undergoing in these centers is diverse and representative of the population.
Ethical approval for this study was obtained from the Institutional Review Board of KFMC. Written informed consents were obtained from the patients before participation.
KSCKD is the main outpatient dialysis unit in Riyadh Second Health Cluster, and the largest dialysis center in Riyadh with a total capacity of 600 patients, and with >52,000 hemodialysis sessions per year.[12 ] The dialysis unit at KFMC, a tertiary hospital at Riyadh Second Health Cluster, has a total capacity of up to 100 patients. KSCKD and KFMC are two of the largest centers for both hemodialysis and peritoneal dialysis not only in Saudi Arabia but also in the Middle East. Therefore, the patient population undergoing in these centers is diverse and representative of the population.
Ethical approval for this study was obtained from the Institutional Review Board of KFMC. Written informed consents were obtained from the patients before participation.
Adult
Cardiovascular Diseases
Diabetes Mellitus
Dialysis
Disorders, Cognitive
Ethics Committees, Research
Hemodialysis
High Blood Pressures
Kidney Diseases
Outpatients
Patients
Peritoneal Dialysis
Top products related to «Hemodialysis»
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, United Kingdom, Germany, China
BNT162b2 is a vaccine candidate developed by Pfizer and BioNTech. It is a messenger RNA (mRNA) vaccine that encodes the SARS-CoV-2 spike protein. The core function of BNT162b2 is to induce an immune response against the SARS-CoV-2 virus.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in Germany, Hong Kong
The Body Composition Monitor is a device used to measure an individual's body composition, including factors such as body fat percentage, muscle mass, and water content. It provides a detailed analysis of the user's overall body composition.
Sourced in United States, United Kingdom
MRNA-1273 is an mRNA-based vaccine candidate developed by Moderna. It is designed to encode the prefusion stabilized full-length spike protein of SARS-CoV-2. The core function of MRNA-1273 is to generate an immune response against the SARS-CoV-2 virus.
Sourced in United States, Japan, United Kingdom, Germany, Austria, Belgium, Denmark, China, Israel, Australia
SPSS version 21 is a statistical software package developed by IBM. It is designed for data analysis and statistical modeling. The software provides tools for data management, data analysis, and the generation of reports and visualizations.
Sourced in Japan
The TKK 5401 Grip-D is a digital force gauge designed for measuring compression and tensile forces. It features a sturdy, ergonomic design and a high-contrast LCD display for clear readouts. The device offers a measurement range of up to 500 N and an accuracy of ±0.5% of the full scale.
Sourced in Germany, United States
The FX100 is a compact centrifuge designed for general laboratory applications. It features a microprocessor-controlled speed and time settings, accommodating a variety of sample volumes and tube sizes. The FX100 provides consistent and reliable performance for routine centrifugation tasks in laboratory environments.
Sourced in Switzerland, Germany, United States, Japan, France, Italy, China, United Kingdom, Sweden
The Cobas 8000 is a modular, automated in-vitro diagnostic system designed for high-throughput clinical chemistry and immunochemistry testing. It is used to perform a wide range of laboratory tests, including those for chemistry, immunoassay, and electrolyte analysis. The Cobas 8000 is capable of processing a large volume of samples efficiently and accurately.
More about "Hemodialysis"
Hemodialysis is a critical medical procedure that plays a vital role in the treatment and management of chronic kidney disease (CKD).
It is a process of purifying the blood of a patient with kidney failure, involving the removal of waste, excess water, and other impurities from the blood using a dialysis machine.
This procedure is typically performed three times per week and can help manage the symptoms associated with end-stage renal disease (ESRD).
Understanding the latest advancements in hemodialysis research is crucial for optimizing patient outcomes and enhancing reproducibility in related studies.
Researchers can leverage tools like PubCompare.ai to locate protocols from literature, preprints, and patents, and utilize AI-driven comparisons to identify the best protocols and products for their hemodialysis studies.
The efficiency and accuracy of hemodialysis can be enhanced through the use of advanced medical equipment and software.
For example, the SAS version 9.4 statistical software can be used to analyze data and optimize treatment protocols.
Additionally, the Body Composition Monitor can provide valuable insights into the patient's overall health status, while the Cobas 8000 analyzer can be used to monitor key biomarkers during the hemodialysis process.
To ensure the safety and efficacy of hemodialysis treatments, it is important to adhere to established protocols and guidelines, such as those developed for the BNT162b2 and MRNA-1273 COVID-19 vaccines.
Similarly, the use of specialized equipment like the TKK 5401 Grip-D and the FX100 can help to improve the consistency and reproducibility of hemodialysis procedures.
By staying up-to-date with the latest advancements in hemodialysis research and technology, healthcare professionals can optimize patient care, enhance treatment outcomes, and contribute to the overall understanding of this critical medical intervention.
It is a process of purifying the blood of a patient with kidney failure, involving the removal of waste, excess water, and other impurities from the blood using a dialysis machine.
This procedure is typically performed three times per week and can help manage the symptoms associated with end-stage renal disease (ESRD).
Understanding the latest advancements in hemodialysis research is crucial for optimizing patient outcomes and enhancing reproducibility in related studies.
Researchers can leverage tools like PubCompare.ai to locate protocols from literature, preprints, and patents, and utilize AI-driven comparisons to identify the best protocols and products for their hemodialysis studies.
The efficiency and accuracy of hemodialysis can be enhanced through the use of advanced medical equipment and software.
For example, the SAS version 9.4 statistical software can be used to analyze data and optimize treatment protocols.
Additionally, the Body Composition Monitor can provide valuable insights into the patient's overall health status, while the Cobas 8000 analyzer can be used to monitor key biomarkers during the hemodialysis process.
To ensure the safety and efficacy of hemodialysis treatments, it is important to adhere to established protocols and guidelines, such as those developed for the BNT162b2 and MRNA-1273 COVID-19 vaccines.
Similarly, the use of specialized equipment like the TKK 5401 Grip-D and the FX100 can help to improve the consistency and reproducibility of hemodialysis procedures.
By staying up-to-date with the latest advancements in hemodialysis research and technology, healthcare professionals can optimize patient care, enhance treatment outcomes, and contribute to the overall understanding of this critical medical intervention.